NCT00658099View on ClinicalTrials.gov

Observational Study of Type 2 Diabetes Patients Failing on Oral Anti-diabetic Agents Initiated on Levemir® or Insulatard®

CompletedOBSERVATIONAL
Enrollment

699

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

insulin detemir

Start dose and frequency prescribed by the physician as a result of a normal clinical evaluation

DRUG

insulin NPH

Start dose and frequency prescribed by the physician as a result of a normal clinical evaluation

Trial Locations (1)

010031

Novo Nordisk Investigational Site, Bucharest

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY